Ilomedin

Iloprost trometamol, the active ingredient in Ilomedin, is a prostacyclin analog presented as a sterile solution for injection for intravenous use. Marketed in the European Union, it is employed in the treatment of pulmonary arterial hypertension and to improve healing of digital ulcers associated with systemic sclerosis.

GNH USA supplies Ilomedin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable cold‑chain logistics and regulatory support, and ensuring product integrity throughout global distribution.

Ilomedin, a prostacyclin analog, acts on the pulmonary vascular system to improve hemodynamics in specific cardiopulmonary conditions.

Pulmonary arterial hypertension: reduces pulmonary arterial pressure and improves exercise capacity. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces formation of new ulcers.

Ilomedin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Flushing: warmth and redness of the skin. - Headache: mild to moderate intensity. - Nausea: occasional episodes. - Jaw pain: mild discomfort during chewing. - Diarrhea: mild gastrointestinal upset. - Hypotension: transient drop in blood pressure.

Serious or Rare Side Effects: - Bleeding: due to platelet inhibition. - Severe hypotension: sustained low blood pressure requiring intervention. - Pulmonary edema: fluid accumulation in the lungs. - Arrhythmias: abnormal heart rhythms that may be life‑threatening.

When using Ilomedin, several precautions should be observed to ensure patient safety. - Dose titration: initiate at a low infusion rate and adjust gradually. - Hemodynamic monitoring: observe blood pressure and heart rate during infusion. - Renal impairment: use with caution in patients with reduced kidney function. - Concomitant anticoagulants: monitor for increased bleeding risk. - Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedin can interact with other medicines; awareness of these interactions helps manage risk.

Major Interactions (Avoid): - Antiplatelet agents: additive inhibition of platelet function. - Potent vasodilators: may cause severe hypotension. - Epoprostenol: overlapping prostacyclin effects increase risk of adverse events.

Moderate Interactions (Monitor Closely): - CYP450 inhibitors: may increase plasma levels of iloprost. - CYP450 inducers: may reduce efficacy of iloprost. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may enhance bleeding risk.